Advertisement

Multi-Modality Imaging in the Evaluation and Treatment of Tricuspid Regurgitation

  • Samuel M. Kim
  • Harsimran S. Singh
  • Jillian Nati
  • Jonathan N. Ginns
Imaging (Q Truong, Section Editor)
  • 171 Downloads
Part of the following topical collections:
  1. Topical Collection on Imaging

Abstract

Purpose of review

The goal of this review is to cover the epidemiology of tricuspid regurgitation (TR), anatomy of the tricuspid valve (TV), and the mechanisms and modern treatment of TR. The focus will be on the role of echocardiography, cardiac CT, and MRI to determine the mechanism, severity, and management strategies of TR.

Recent findings

The evaluation and management of TR is a rapidly growing field with significant advances in both imaging and interventions. Important advances have been made to understand TV anatomy and physiology in 3D echo, CT, and MRI. Additional understanding of the abnormal outcomes in both primary TR and secondary TR have been appreciated. Multiple transcatheter devices have reached the stage of early trials in high surgical risk cohorts with favorable initial findings.

Summary

TR is a significant cardiovascular problem and vastly undertreated in the present era. There has been tremendous growth in knowledge of mechanisms of TR, its prognostic implications, timing of intervention, and development of novel treatment strategies. Multimodality imaging plays a key role in evaluation and treatment of this condition.

Keywords

Tricuspid regurgitation Tricuspid valve Multi-modality imaging Valvular heart disease Transcatheter intervention 

Notes

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Singh JP, Evans JC, Levy D, Larson MG, Freed LA, Fuller DL, et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham heart study). Am J Cardiol. 1999;83(6):897–902.Google Scholar
  2. 2.
    Stuge O, Liddicoat J. Emerging opportunities for cardiac surgeons within structural heart disease. J Thorac Cardiovasc Surg. 2006;132(6):1258–61.CrossRefPubMedGoogle Scholar
  3. 3.
    Rogers JH, Bolling SF. The tricuspid valve: current perspective and evolving management of tricuspid regurgitation. Circulation. 2009;119(20):2718–25.CrossRefPubMedGoogle Scholar
  4. 4.
    Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol. 2004;43(3):405–9.CrossRefPubMedGoogle Scholar
  5. 5.
    Mutlak D, Lessick J, Khalil S, Yalonetsky S, Agmon Y, Aronson D. Tricuspid regurgitation in acute heart failure: is there any incremental risk? Eur heart J Cardiovasc imaging. 2018.Google Scholar
  6. 6.
    Medvedofsky D, Leon Jimenez J, Addetia K, Singh A, Lang RM, Mor-Avi V, et al. Multi-parametric quantification of tricuspid regurgitation using cardiovascular magnetic resonance: A comparison to echocardiography. Eur J Radiol. 2017;86:213–20.CrossRefPubMedGoogle Scholar
  7. 7.
    Zilberszac R, Gleiss A, Binder T, Laufer G, Grimm M, Gabriel H, et al. Prognostic relevance of mitral and tricuspid regurgitation in patients with severe aortic stenosis. Eur Heart J Cardiovasc Imaging. 2018:1.Google Scholar
  8. 8.
    Lindman BR, Maniar HS, Jaber WA, Lerakis S, Mack MJ, Suri RM, et al. Effect of tricuspid regurgitation and the right heart on survival after transcatheter aortic valve replacement: insights from the placement of aortic Transcatheter valves II inoperable cohort. Circ Cardiovasc Interv. 2015;8(4):e002073.  https://doi.org/10.1161/CIRCINTERVENTIONS.114.002073.
  9. 9.
    Schwartz LA, Rozenbaum Z, Ghantous E, Kramarz J, Biner S, Ghermezi M, et al. Impact of right ventricular dysfunction and tricuspid regurgitation on outcomes in patients undergoing Transcatheter aortic valve replacement. J Am Soc Echocardiogr. 2017;30(1):36–46.Google Scholar
  10. 10.
    Yzeiraj E, Bijuklic K, Tiburtius C, Witt J, Krause K, Steude J, et al. Tricuspid regurgitation is a predictor of mortality after percutaneous mitral valve edge-to-edge repair. Euro Intervention. 2017;12(15):e1817–24.Google Scholar
  11. 11.
    • Alqahtani F, Berzingi CO, Aljohani S, Hijazi M, Al-Hallak A, Alkhouli M. Contemporary trends in the use and outcomes of surgical treatment of tricuspid regurgitation. J Am Heart Assoc. 2017;6(12):e007597.  https://doi.org/10.1161/JAHA.117.007597. This interesting study shows increasing utilization of tricuspid surgery in the contemporary era, though mortality/morbidity remains high.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Arsalan M, Walther T, Smith RL 2nd, Grayburn PA. Tricuspid regurgitation diagnosis and treatment. Eur Heart J. 2017;38(9):634–8.PubMedGoogle Scholar
  13. 13.
    Ancona F, Agricola E, Stella S, Capogrosso C, Marini C, Margonato A, et al. Interventional imaging of the tricuspid valve. Interv Cardiol Clin. 2018;7(1):13–29.PubMedGoogle Scholar
  14. 14.
    Russo M, Kuwata S, Pozzoli A, Maisano F, Taramasso M. Understanding the tricuspid valve for transcatheter valve repair: comparative anatomy of different imaging modalities. Eur Heart J Cardiovasc Imaging. 2017 Jul 1;18(7):823.CrossRefPubMedGoogle Scholar
  15. 15.
    Ancona F, Stella S, Taramasso M, Marini C, Latib A, Denti P, et al. Multimodality imaging of the tricuspid valve with implication for percutaneous repair approaches. Heart. 2017 Jul;103(14):1073–81.Google Scholar
  16. 16.
    Ginns J, Ammash N, Bernier PL. The tricuspid valve in adult congenital heart disease. Heart Fail Clin. 2014 Jan;10(1):131–53.CrossRefPubMedGoogle Scholar
  17. 17.
    Antunes MJ, Barlow JB. Management of tricuspid valve regurgitation. Heart. 2007 Feb;93(2):271–6.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Shah PM, Raney AA. Tricuspid valve disease. Curr Probl Cardiol. 2008 Feb;33(2):47–84.CrossRefPubMedGoogle Scholar
  19. 19.
    Starck CT, Kempfert J, Falk V. Tricuspid valve interventions: surgical techniques and outcomes. EuroIntervention 2015 Sep;11 Suppl W:W128–W132.Google Scholar
  20. 20.
    • Utsunomiya H, Itabashi Y, Mihara H, Berdejo J, Kobayashi S, Siegel RJ, et al. Functional tricuspid regurgitation caused by chronic atrial fibrillation: a real-time 3-dimensional transesophageal echocardiography study. Circ Cardiovasc Imaging. 2017 Jan;10(1):e004897.  https://doi.org/10.1161/CIRCIMAGING.116.004897. This interesting study highlights the incidence and assessment of this increasingly appreciated TR-AF in mostly elderly, female patients with AF, without pulmonary hypertension.
  21. 21.
    Ejiofor JI, Neely RC, Yammine M, McGurk S, Kaneko T, Leacche M, et al. Surgical outcomes of isolated tricuspid valve procedures: repair versus replacement. Ann Cardiothorac Surg. 2017;6(3):214–22.Google Scholar
  22. 22.
    Trankle CR, Gertz ZM, Koneru JN, Kasirajan V, Nicolato P, Bhardwaj HL, et al. Severe tricuspid regurgitation due to interactions with right ventricular permanent pacemaker or defibrillator leads. Pacing Clin Electrophysiol. 2018:14.Google Scholar
  23. 23.
    • Schleifer JW, Pislaru SV, Lin G, Powell BD, Espinosa R, Koestler C, et al. Effect of ventricular pacing lead position on tricuspid regurgitation: A randomized prospective Trials Heart Rhythm 2018 Mar 1. This small, randomized study shows no effect of varying pacemaker location on the incidence of AF post procedure.Google Scholar
  24. 24.
    • Woudstra OI, Bokma JP, Winter MM, Kies P, Jongbloed MRM, Vliegen HW, et al. Clinical course of tricuspid regurgitation in repaired tetralogy of Fallot. Int J Cardiol. 2017;243:191–3. This article is of importance to the ACHD community and highlights the increasing importance of acquired valvular disease in the grown up survivors of these complex conditions.CrossRefPubMedGoogle Scholar
  25. 25.
    Tanase D, Ewert P, Georgiev S, Meierhofer C, Pabst von Ohain J, McElhinney DB, et al. Tricuspid regurgitation does not impact right ventricular remodeling after percutaneous pulmonary valve implantation. JACC Cardiovasc Interv. 2017;10(7):701–8.CrossRefPubMedGoogle Scholar
  26. 26.
    Takaya Y, Akagi T, Kijima Y, Nakagawa K, Ito H. Functional tricuspid regurgitation after Transcatheter closure of atrial septal defect in adult patients. Long-Term Follow-Up JACC Cardiovasc Interv. 2017;10(21):2211–8.CrossRefPubMedGoogle Scholar
  27. 27.
    • Hahn RT. State-of-the-art review of echocardiographic imaging in the evaluation and treatment of functional tricuspid regurgitation. Circ Cardiovasc Imaging. 2016;9(12):e005332.  https://doi.org/10.1161/CIRCIMAGING.116.005332. Excellent review of echo imaging of the tricuspid valve.CrossRefPubMedGoogle Scholar
  28. 28.
    Sun YP, O'Gara PT. Epidemiology, anatomy, pathophysiology and clinical evaluation of functional tricuspid regurgitation. Minerva Cardioangiol. 2017 Oct;65(5):469–79.PubMedGoogle Scholar
  29. 29.
    Shah S, Jenkins T, Markowitz A, Gilkeson R, Rajiah P. Multimodal imaging of the tricuspid valve: normal appearance and pathological entities. Insights Imaging. 2016;7(5):649–67.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Lancellotti P, Tribouilloy C, Hagendorff A, Popescu BA, Edvardsen T, Pierard LA, et al. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2013 Jul;14(7):611–44.Google Scholar
  31. 31.
    •• van Rosendael PJ, Kamperidis V, Kong WK, van Rosendael AR, van der Kley F, Ajmone Marsan N, et al. Computed tomography for planning transcatheter tricuspid valve therapy. Eur Heart J. 2017;38(9):665–74. Important study that lays the groundwork for better anatomical understanding using CT prior to transcatheter interventions.Google Scholar
  32. 32.
    • Feneis JF, Kyubwa E, Atianzar K, Cheng JY, Alley MT. Vasanawala SS, et al. 4D flow MRI quantification of mitral and tricuspid regurgitation: reproducibility and consistency relative to conventional MRI. J Magn Reson Imaging. 2018:11. This small study demonstrates the accuracy of 4D flow PC MRI, which undoubtedly will become more widespread in use in the coming decade.Google Scholar
  33. 33.
    • Park JB, Kim HK, Jung JH, Klem I, Yoon YE, Lee SP, et al. Prognostic value of cardiac MR imaging for preoperative assessment of patients with severe functional tricuspid regurgitation. Radiology. 2016;280(3):723–34. This study demonstrates MRI can be prognostically helpful in predicting outcomes of surgery in isolated severe TR.Google Scholar
  34. 34.
    Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP. 3rd, Fleisher LA, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the Management of Patients with Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Circulation. 2017;135(25):e1159–95.CrossRefPubMedGoogle Scholar
  35. 35.
    Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010;23(7):685,713. quiz 786–8CrossRefGoogle Scholar
  36. 36.
    Naoum C, Blanke P, Cavalcante JL, Leipsic J. Cardiac computed tomography and magnetic resonance imaging in the evaluation of mitral and tricuspid valve disease: implications for Transcatheter interventions. Circ Cardiovasc Imaging. 2017;10(3):e005331.  https://doi.org/10.1161/CIRCIMAGING.116.005331.CrossRefPubMedGoogle Scholar
  37. 37.
    Kelly BJ, Ho Luxford JM, Butler CG, Huang CC, Wilusz K, Ejiofor JI, et al. Severity of tricuspid regurgitation is associated with long-term mortality. J Thorac Cardiovasc Surg. 2018;155(3):1032,1038.e2.CrossRefGoogle Scholar
  38. 38.
    Braunwald NS, Ross J. Jr, morrow AG. Conservative management of tricuspid regurgitation in patients undergoing mitral valve replacement. Circulation. 1967;35(4 Suppl):I63–9.PubMedGoogle Scholar
  39. 39.
    Del Forno B, Lapenna E, Dalrymple-Hay M, Taramasso M, Castiglioni A, Alfieri O, et al. Recent advances in managing tricuspid regurgitation. F1000Res. 2018;7:355.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    • Pagnesi M, Montalto C, Mangieri A, Agricola E, Puri R, Chiarito M, et al. Tricuspid annuloplasty versus a conservative approach in patients with functional tricuspid regurgitation undergoing left-sided heart valve surgery: a study-level meta-analysis. Int J Cardiol. 2017;240:138–44. This study supports the current guidelines by demonstrating mortality benefit to this approach.Google Scholar
  41. 41.
    Wang N, Phan S, Tian DH, Yan TD, Phan K. Flexible band versus rigid ring annuloplasty for tricuspid regurgitation: a systematic review and meta-analysis. Ann Cardiothorac Surg. 2017;6(3):194–203.CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Fender EA, Nishimura RA, Holmes DR. Percutaneous therapies for tricuspid regurgitation. Expert Rev Med Devices. 2017;14(1):37–48.CrossRefPubMedGoogle Scholar
  43. 43.
    Fender EA, Zack CJ, Nishimura RA. Isolated tricuspid regurgitation: outcomes and therapeutic interventions. Heart. 2018 May;104(10):798–806.CrossRefPubMedGoogle Scholar
  44. 44.
    •• McElhinney DB, Cabalka AK, Aboulhosn JA, Eicken A, Boudjemline Y, Schubert S, et al. Transcatheter tricuspid valve-in-valve implantation for the treatment of dysfunctional surgical bioprosthetic valves: an international, multicenter registry study. Circulation. 2016;133(16):1582–93. Landmark study demonstrating the feasibility of tricuspid valve-in-valve.Google Scholar
  45. 45.
    Navia JL, Kapadia S, Elgharably H, Harb SC, Krishnaswamy A, Unai S, et al. First-in-human implantations of the NaviGate bioprosthesis in a severely dilated tricuspid annulus and in a failed tricuspid Annuloplasty ring. Circ Cardiovasc Interv. 2017;10(12):e005840.  https://doi.org/10.1161/CIRCINTERVENTIONS.117.005840.
  46. 46.
    Taramasso M, Hahn RT, Alessandrini H, Latib A, Attinger-Toller A, Braun D, et al. The international multicenter TriValve registry: which patients are undergoing Transcatheter tricuspid repair? JACC Cardiovasc Interv. 2017;10(19):1982–90.Google Scholar
  47. 47.
    Rodes-Cabau J, Hahn RT, Latib A, Laule M, Lauten A, Maisano F, et al. Transcatheter therapies for treating tricuspid regurgitation. J Am Coll Cardiol. 2016;67(15):1829–45.CrossRefPubMedGoogle Scholar
  48. 48.
    Lauten A, Figulla HR, Unbehaun A, Fam N, Schofer J, Doenst T, et al. Interventional treatment of severe tricuspid regurgitation: early clinical experience in a multicenter, observational, first-in-man study. Circ Cardiovasc Interv. 2018;11(2):e006061.Google Scholar
  49. 49.
    Schofer J. Transcatheter interventions for tricuspid regurgitation: Trialign and Mitralign. Euro Intervention. 2016;12(Y):Y119–20.PubMedGoogle Scholar
  50. 50.
    Orban M, Besler C, Braun D, Nabauer M, Zimmer M, Orban M, et al. Six-month outcome after transcatheter edge-to-edge repair of severe tricuspid regurgitation in patients with heart failure. Eur J Heart Fail. 2018;20(6):1055–62.Google Scholar
  51. 51.
    Rogers T, Ratnayaka K, Sonmez M, Franson DN, Schenke WH, Mazal JR, et al. Transatrial Intrapericardial tricuspid Annuloplasty. JACC Cardiovasc Interv. 2015;8(3):483–91.Google Scholar
  52. 52.
    Stephan von Bardeleben R, Tamm A, Emrich T, Munzel T, Schulz E. Percutaneous transvenous direct annuloplasty of a human tricuspid valve using the Valtech Cardioband. Eur Heart J. 2017;38(9):690.CrossRefPubMedGoogle Scholar
  53. 53.
    Rogers JH, Boyd WD, Smith TWR, Ebner AA, Bolling SF. Combined MitraClip edge-to-edge repair with millipede IRIS mitral Annuloplasty. JACC Cardiovasc Interv. 2018;11(3):323–4.CrossRefPubMedGoogle Scholar
  54. 54.
    Perlman G, Praz F, Puri R, Ofek H, Ye J, Philippon F, et al. Transcatheter tricuspid valve repair with a new Transcatheter Coaptation system for the treatment of severe tricuspid regurgitation: 1-year clinical and echocardiographic results. JACC Cardiovasc Interv. 2017;10(19):1994–2003.Google Scholar
  55. 55.
    Pfister R, Baldus S. MitraClip(R) for treatment of tricuspid valve insufficiency. Herz. 2017;42(7):644–50.CrossRefPubMedGoogle Scholar
  56. 56.
    Kalra A, Uberoi AS, Latib A, Khera S, Little SH, Bhatt DL, et al. Emerging Transcatheter Options for Tricuspid Regurgitation, 2017. Methodist Debakey Cardiovasc J. 13(3):120–5.Google Scholar
  57. 57.
    Utsunomiya H, Itabashi Y, Mihara H, Kobayashi S, De Robertis MA, Trento A, et al. Usefulness of 3D echocardiographic parameters of tricuspid valve morphology to predict residual tricuspid regurgitation after tricuspid annuloplasty. Eur Heart J Cardiovasc Imaging. 2017;18(7):809–17.CrossRefPubMedGoogle Scholar
  58. 58.
    Pozzoli A, Taramasso M, Zuber M, Maisano F. Transcatheter tricuspid valve repair with the MitraClip system using intracardiac echocardiography: proof of concept. EuroIntervention. 2017;13(12):e1452–3.CrossRefPubMedGoogle Scholar
  59. 59.
    • Prihadi EA, Delgado V, Hahn RT, Leipsic J, Min JK, Bax JJ. Imaging needs in novel Transcatheter tricuspid valve interventions. JACC Cardiovasc Imaging. 2018;11(5):736–54. Important review of anatomy, imaging and transcatheter techniques in TR with excellent illustrations.CrossRefPubMedGoogle Scholar
  60. 60.
    Chan JL, Mazilu D, Miller JG, Hunt T, Horvath KA, Li M. Robotic-assisted real-time MRI-guided TAVR: from system deployment to in vivo experiment in swine model. Int J Comput Assist Radiol Surg. 2016;11(10):1905–18.CrossRefPubMedGoogle Scholar
  61. 61.
    Heterotopic Implantation Of the Edwards-Sapien Transcatheter Aortic Valve in the Inferior VEna Cava for the Treatment of Severe Tricuspid Regurgitation (HOVER). https://clinicaltrials.gov/ct2/show/NCT02339974. Accessed 25 June 2018.
  62. 62.
    Treatment of Severe Secondary TRIcuspid Regurgitation in Patients With Advance Heart Failure With CAval Vein Implantation of the Edwards Sapien XT VALve (TRICAVAL). https://clinicaltrials.gov/ct2/show/NCT02387697. Accessed 25 June 2018.
  63. 63.
    Early Feasibility of the Mitralign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS) Also Known as TriAlign™(SCOUT). https://clinicaltrials.gov/ct2/show/NCT02574650. Accessed 25 June 2018.
  64. 64.
    Percutaneous Treatment of Tricuspid Valve Regurgitation With the TriCinch System™ (PREVENT). https://clinicaltrials.gov/ct2/show/NCT02098200. Accessed 25 June 2018.
  65. 65.
    The SPACER Trial - Repair of Tricuspid Valve Regurgitation Using the Edwards TricuSPid TrAnsCatheter REpaiR System (SPACER). https://clinicaltrials.gov/ct2/show/NCT02787408. Accessed 25 June 2018.

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Samuel M. Kim
    • 1
  • Harsimran S. Singh
    • 1
  • Jillian Nati
    • 1
  • Jonathan N. Ginns
    • 1
  1. 1.Division of Cardiology, Department of MedicineNewYork Presbyterian Hospital-Weill Cornell MedicineNew YorkUSA

Personalised recommendations